Cysteine
- Generic Name
- Cysteine
- Brand Names
- Elcys, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Nouress, Premasol, Primene, Procalamine 3, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C3H7NO2S
- CAS Number
- 52-90-4
- Unique Ingredient Identifier
- K848JZ4886
- Background
A thiol-containing non-essential amino acid that is oxidized to form cystine.
- Indication
For the prevention of liver damage and kidney damage associated with overdoses of acetaminophen
- Associated Therapies
- Total parenteral nutrition therapy, Amino acid supplementation
The FIGHT-RP1 Study
- First Posted Date
- 2017-02-24
- Last Posted Date
- 2022-09-19
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 30
- Registration Number
- NCT03063021
- Locations
- 🇺🇸
Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland, United States
Antioxidant Use in Diabetes to Reduce Oxidative Stress
- Conditions
- Ameliorating Oxidative Stress in Type 1 Diabetes
- Interventions
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 8
- Registration Number
- NCT03056014
- Locations
- 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States
N-Acetylcysteine for Youth Cannabis Use Disorder
- Conditions
- Cannabis Use Disorder
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 192
- Registration Number
- NCT03055377
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar Offspring
- First Posted Date
- 2016-08-12
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 22
- Registration Number
- NCT02865629
- Locations
- 🇺🇸
University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience, Cincinnati, Ohio, United States
A Study of Oxidative Pathways in MS Fatigue
- Conditions
- FatigueProgressive Multiple Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 15
- Registration Number
- NCT02804594
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
Glutathione Levels and Compulsivity
- Conditions
- Compulsive BehaviorAnorexia Nervosa
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-06-09
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 23
- Registration Number
- NCT02794389
- Locations
- 🇬🇧
Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom
NAC Trial for Anosmia
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 29
- Registration Number
- NCT02481609
- Locations
- 🇺🇸
University of Miami, Miller School of Medicine, Clinical Research Building, Miami, Florida, United States
N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Procedure: laparoscopic ovarian drilling
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2014-09-12
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 70
- Registration Number
- NCT02239107
A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
- Conditions
- Hypoglycemia UnawarenessType 1 Diabetes
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-08-01
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 22
- Registration Number
- NCT02206152
- Locations
- 🇺🇸
University of Minnesota Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Minneapolis, Minnesota, United States
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS
- Conditions
- HealthyCocaine Dependence
- Interventions
- Diagnostic Test: 1H MRSDiagnostic Test: [11C]APP311 PET scanDiagnostic Test: [18F]FDG PET scan
- First Posted Date
- 2014-04-28
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- Yale University
- Target Recruit Count
- 6
- Registration Number
- NCT02124941
- Locations
- 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.